The Securities and Exchange Commission (SEC) has obtained a final judgment against stock promoter Carl Smith for misrepresentations he made to investors while raising funds for Nanobeak Biotech Inc.
The judgment was issued by the U.S. District Court for the Southern District of New York earlier in January.
According to the SEC’s complaint, filed on December 9, 2020, between at least December 2015 and December 2019, Nanobeak Biotech Inc. and its former CEO, Jeremy Barbera, solicited and sold Nanobeak securities using false and misleading statements. During this period, Nanobeak and Barbera, with the help of Smith, sold securities to at least 37 investors, raising a total of approximately $3.6 million.
Smith consented to the entry of a final judgment permanently enjoining him from violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The final judgment also ordered Smith to pay a civil money penalty of $100,000, and ordered disgorgement of $173,875, plus $23,470.59 in prejudgment interest.#sec#
风险提示：以上内容仅代表作者或嘉宾的观点，不代表 FOLLOWME 的任何观点及立场，且不代表 FOLLOWME 同意其说法或描述，也不构成任何投资建议。对于访问者根据 FOLLOWME 社区提供的信息所做出的一切行为，除非另有明确的书面承诺文件，否则本社区不承担任何形式的责任。
FOLLOWME 交易社区网址: www.followme.asia
加载失败()